Spectrum of radiopharmaceuticals in nuclear oncology.

Denoyer, Delphine, Perek, N, Le Jeune, N and Dubois, F 2006, Spectrum of radiopharmaceuticals in nuclear oncology., Current cancer drug targets, vol. 6, no. 3, pp. 181-196, doi: 10.2174/156800906776842984.

Attached Files
Name Description MIMEType Size Downloads

Title Spectrum of radiopharmaceuticals in nuclear oncology.
Author(s) Denoyer, DelphineORCID iD for Denoyer, Delphine orcid.org/0000-0001-8932-5116
Perek, N
Le Jeune, N
Dubois, F
Journal name Current cancer drug targets
Volume number 6
Issue number 3
Start page 181
End page 196
Total pages 16
Publisher Bentham Science Publishers
Publication date 2006
ISSN 1568-0096
Keyword(s) Science & Technology
Life Sciences & Biomedicine
Oncology
tumor imaging
PET
SPECT
multidrug resistance
angiogenesis
POSITRON-EMISSION-TOMOGRAPHY
P-GLYCOPROTEIN EXPRESSION
IN-VIVO EVALUATION
PENTAVALENT DIMERCAPTOSUCCINIC ACID
NONFUNCTIONING PITUITARY-ADENOMAS
RESISTANCE-ASSOCIATED PROTEIN
MONITORING TUMOR RESPONSE
PROGRAMMED CELL-DEATH
TC-99M ANNEXIN-V
PROSTATE-CANCER
Language eng
DOI 10.2174/156800906776842984
Field of Research 0304 Medicinal And Biomolecular Chemistry
1112 Oncology And Carcinogenesis
1115 Pharmacology And Pharmaceutical Sciences
HERDC Research category CN.1 Other journal article
Persistent URL http://hdl.handle.net/10536/DRO/DU:30075162

Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 14 times in TR Web of Science
Scopus Citation Count Cited 16 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 38 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Fri, 14 Aug 2015, 11:58:52 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.